Malignancy risk in patients with rheumatoid arthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a 5-year population-based cohort study
Therapeutic Advances in Musculoskeletal Disease
Published online on February 23, 2026
Abstract
Therapeutic Advances in Musculoskeletal Disease, Volume 18, January-December 2026.
Background:Data regarding malignancy risk amongst rheumatoid arthritis (RA) patients using biological and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) was conflicting, and real-world Taiwanese data was lacking.Objectives:To ...
Background:Data regarding malignancy risk amongst rheumatoid arthritis (RA) patients using biological and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) was conflicting, and real-world Taiwanese data was lacking.Objectives:To ...